Lhasa Limited shared knowledge shared progress

Archive

This is a library of Lhasa's blog articles. 

  • One of the most influential scientific papers blog2
    Clock: less than 5 minutesless than 5 minutes

    One of the most influential scientific papers of 2022

    In November last year, we published a ground-breaking article to Chemical Research in Toxicology titled ‘What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships’.  

    Within the paper, we show that certain structural features, when treated independently, have a statistically significant impact on the carcinogenic potency of nitrosamines. It is with great excitement that we share this publication making it to Chemical Research in Toxicology’s top 20 most downloaded articles, as well as being the most viewed article within their November edition. 

    26 January 2023

  • “Welcome to 2023” – Chris Barber, Lhasa CEO

    “Welcome to 2023” – Chris Barber, Lhasa CEO

    In our first blog of 2023, Chris Barber (our CEO) shares his thoughts on our 2022 success, BHAG* progress, and more. 

    *We explain BHAG in the article, just in case you are wondering…

    06 January 2023

  • A day in the life of a Software Developer - Jessica
    less than 10 minutes

    A day in the life of a Software Developer at Lhasa Limited

    Hola! My name is Jessica Magallanes-Castaneda. I am originally from Mexico and moved to the UK in 2015 to pursue my MSc and PhD in Computer Science at The University of Sheffield. Keep reading on to see my typical day as a Software Developer at Lhasa!

    09 December 2022

  • A day in the life of a Business Support Manager   Oana
    less than 10 minutes

    A day in the life of a Business Support Manager at Lhasa Limited

    Hello, my name is Oana Leonte, and I work in the Business Support Team at Lhasa Limited as a Business Support Manager.

    In my role I provide support to many different functions across the organisation, this includes our Marketing, Applied Sciences and Business Partnerships teams. My role is very varied and relies on attention to detail and organisational skills to accommodate travel bookings and events planning, amongst other areas of support.

    Read on to discover what a day in the life of a Business Support Manager at Lhasa can look like!

    24 November 2022

  • ICH M7 blog new
    Clock: 5 minutes5 minutes

    How to calculate the safe limit for carcinogens as per ICH M7

    Mutagenic impurities can be expected in any drug product; however, this is not a concern providing they are present below the safe limit. The objective of a carcinogenicity study is to identify compounds that can cause tumours in animals, which is imperative to understanding the cancer risk posed to humans.

    07 November 2022

  • Leeds Digital Festival award winners
    Clock: less than 5 minutesless than 5 minutes

    Leeds Digital Festival award winners

    We are absolutely thrilled to have won theTech4Good (Product) award at the 2022 Leeds Digital Festival!

    18 October 2022

  • Complex nitrosamines blog
    Clock: less than 5 minutesless than 5 minutes

    The benefits of joining the Complex Nitrosamines consortium

    Read what one of our Complex Nitrosamines Data Sharing Initiative members, Graham Smith, Oncology Chemical Toxicology Lead at AstraZeneca, has to say about being involved in this growing consortium!

    10 October 2022

  • A day in the life of a Business Partnerships Manager - Raeesah Saddiq
    less than 10 minutes

    A day in the life of a Business Partnerships Manager at Lhasa Limited

    Hi, my name is Raeesah and I work in the Business Partnerships Team here at Lhasa Limited!

    Read on to discover what a typical day in the life of a Business Partnerships Manager working from home on a Tuesday looks like!

    30 August 2022

  • blog 3
    Clock: less than 5 minutesless than 5 minutes

    Ensuring data quality in Vitic; three benchmarks for data quality success

    Evaluating the potential toxicity of chemicals is an important part of the drug development process. Optimizing a data set that provides quality over quantity is critical in the search for suitable drug candidates. 

    26 August 2022

  • Using existing data better, relying less on animal testing
    Clock: less than 5 minutesless than 5 minutes

    Using existing data better and relying less on animal testing

    I recently read that by 2025, 36% of world data will be healthcare data. (Yes, thirty-six percent!). Considering this statistic, now more than ever, it is important that we are working to ensure existing data is utilised to make better safety assessment decisions more quickly - whilst also relying less on animal testing.

    04 August 2022

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).